Associate Director FP&A, Quell Therapeutics
Maternity Cover
+ Annual Bonus
Office located in Wood Lane, London
Cell therapy company
Open for applications
Cell therapy company
101-200 employees
Open for applications
+ Annual Bonus
Office located in Wood Lane, London
101-200 employees
Company mission
To develop engineered T regulatory (Treg) cell therapies.
Role
Who you are
- The ideal candidate will be proactive and capable of working in a fast-paced, entrepreneurial environment
- Qualified Accountant from a recognised body with at least 7 years PQE
- Strong communication and presentation skills, with the ability to translate complex financial data into clear insights
- Life sciences industry experience is an advantage but not essential
- Strong competency in financial software (NetSuite an advantage) and Microsoft applications including Excel, SharePoint, Word, and PowerPoint
- Strong proficiency in financial modelling, forecasting, and budgeting
What the job involves
- The Associate Director of FP&A will be responsible for managing the financial planning, forecasting, and analytical initiatives of the organisation
- This role requires a self-starter with an analytical and detail-oriented mindset alongside strong financial modelling skills
- Financial Planning and Forecasting
- Lead the annual budgeting and periodic forecasting processes, working closely with business units to set achievable and strategic financial goals
- Develop and maintain comprehensive financial models to support strategic planning, including multi-year forecasting
- Conduct variance analysis to compare actual results against budgets and forecasts, identifying trends, risks, and opportunities
- Assist in management of cash flow forecast for treasury management role carried out in Accounting
- Management Reporting & Analysis
- Prepare and present monthly, quarterly, and annual financial reports to executive management, summarizing key insights and recommendations
- Develop key performance indicators (KPIs) to track business performance and provide actionable insights
- Produce ad hoc reports and financial analysis to support strategic initiatives and operational decisions as required
- Cross-Functional Collaboration
- Partner with departments such as Research, Manufacturing, Clinical operations, and across G&A to gather inputs and assumptions for financial planning and forecasting
- Collaborate with department heads to optimise budgeting and forecasting processes, enhancing financial visibility and accountability
- Serve as a finance liaison to ensure alignment between financial planning and operational execution
- Process Improvement & Systems Optimization
- Identify opportunities to streamline financial processes, improve data accuracy, and enhance reporting capabilities
- Implement or improve FP&A tools and systems to increase efficiency in budgeting, forecasting, and reporting processes
- Develop and implement best practices in financial planning, modelling, and analysis
- Support strategic decision-making by providing financial analysis and modelling for various projects and initiatives
- Oversee FP&A function and team
- Manage and mentor the FP&A team (1 FP&A Manager), fostering a culture of continuous improvement and professional development
Salary benchmarks
Our take
T-regulator (Treg) cells play a crucial role in modulating immune responses and maintaining immune tolerance. However, in certain diseases, such as autoimmune disorders, the balance of the immune system is disrupted. Quell Therapeutics is a biotechnology company that aims to address these conditions by engineering Treg cells to enhance their therapeutic potential and direct their immune-suppressive properties towards specific disease targets.
Quell Therapeutics has been recognised as a leader in the field of Treg cell therapies. Building upon its expertise, the company recently partnered with Cellistic, an iPSC-focused cell therapy platform. This collaboration allows Quell Therapeutics to expand its pipeline and take advantage of the capabilities of Cellistic's platform in order to further enhance the development of its Treg cell therapies.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 3 rounds)
Nov 2021
$156m
SERIES B
Feb 2021
$35.7m
SERIES A
Total funding: $236.2m
Company benefits
- Holidays: 25 days per year
- Life Assurance: 4 x base salary
- Group Personal Pension: Auto enrolled at 6% employer contribution, 3% employee contribution
- Private Medical Insurance for your whole family
- Annual Bonus
- Flexible working environment
Company values
- Collaborative
- Innovative
- Respectful
- Accountable
- Integrity
Company HQ
London, UK
Articles
Leadership
Marc Martinez-Llordella
(Co-Founder)Received a PhD in Biomedicine from the University of Barcelona. Previously worked as a Lecturer at the King's College London.
Share this job